28 Feb, 09:39 - Indian

SENSEX 73739.96 (-1.17)

Nifty 50 22279.65 (-1.18)

Nifty Bank 48274.6 (-0.96)

Nifty IT 37756.6 (-3.06)

Nifty Midcap 100 47917.05 (-2.48)

Nifty Next 50 57626.55 (-1.94)

Nifty Pharma 19854.55 (-1.72)

Nifty Smallcap 100 14805.15 (-2.32)

28 Feb, 09:39 - Global

NIKKEI 225 36975.25 (-3.35)

HANG SENG 23171.69 (-2.30)

S&P 5877.5 (-0.18)

Login/Signup
LOGIN HERE
Cancel

companylogoAjooni Biotech Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 535040 | NSE Symbol : AJOONI | ISIN : INE820Y01021 | Industry : Food - Processing - Indian |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
04-Feb-2025 13-Feb-2025 Quarterly Results To consider and approve the financial results for the period ended December 31, 2024 Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on February 13, 2025. (As Per NSE Announcement Dated on: 13.02.2025)
24-Dec-2024 03-Jan-2025 Change in Directors To consider Fund Raising AJOONI : 03-Jan-2025 : The Company has informed the Exchange that a Board meeting to be held on December 31, 2024 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on January 03, 2025, To consider Fund Raising and other business matters (As Per NSE Announcement Dated on: 31/12/2024) Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on January 03, 2025. (As Per NSE Announcement Dated on: 03.01.2025)
04-Nov-2024 13-Nov-2024 Quarterly Results To consider and approve the financial results for the period ended September 30, 2024 Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on November 13, 2024. (As Per NSE Announcement Dated on: 13/11/2024)
09-Dec-2024 13-Nov-2024 Quarterly Results Ajooni Biotech Limited has informed the Exchange regarding 'Submission of Outcome of the Board Meeting held on Wednesday, November 13, 2024, pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 in Machine Readable Format'.
09-Aug-2024 16-Aug-2024 Change in Auditors To consider other business matters Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on August 16, 2024. (As Per NSE Announcement Dated on:16/08/2024)
01-Aug-2024 09-Aug-2024 Quarterly Results Financial Results Ajooni Biotech Limited has submitted to the Exchange, the financial results for the period ended June 30, 2024. Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on August 09, 2024. (As Per NSE Announcement Dated on: 09/08/2024) Ajooni Biotech Limited has informed the Exchange regarding 'Submission of Un-audited Financial Results for the quarter ended June 30, 2024 in MACHINE READABLE FORMAT'. (As Per NSE Announcement Dated on: 21/08/2024)
13-May-2024 20-May-2024 Quarterly Results To consider and approve the financial results for the period ended March 31, 2024 Ajooni Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2024. Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on May 20, 2024. (As Per NSE Announcement Dated on: 20/05/2024)
30-Jan-2024 07-Feb-2024 Quarterly Results To consider and approve the un-audited financial results for the period ended December 31, 2023 and other business matters. Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on February 07, 2024. (As Per NSE Announcement Dated on: 07/02/2024)
01-Nov-2023 09-Nov-2023 Quarterly Results To consider and approve the financial results for the period ended September 30, 2023 Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on November 09, 2023. (As Per NSE Announcement Dated on: 09/11/2023)
06-Oct-2023 14-Oct-2023 Right Issue To consider Fund Raising Ajooni Biotech Limited has informed the Exchange regarding the Board meeting held on October 14, 2023, to consider Fundraising through the right issue and other matters. (As Per NSE Announcement Dated on: 14/10/2023)
26-Jul-2023 03-Aug-2023 Quarterly Results To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters AJOONI BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 03-Aug-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2023 and Increase in authorised capital/Other business. Ajooni Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on August 03, 2023. Ajooni Biotech Limited has submitted to the Exchange, the financial results for the period ended June 30, 2023. Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on August 03, 2023. (As Per NSE Announcement Dated on 03/08/2023)
10-May-2023 18-May-2023 Accounts To consider and approve the financial results for the period ended March 31, 2023 AJOONI BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 18-May-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2023 . Ajooni Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on May 18, 2023. Ajooni Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2023. Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on May 18, 2023. (As Per NSE Announcement Dated on 18/05/2023)
21-Apr-2023 21-Apr-2023 Change in Auditors Ajooni Biotech Limited has informed the Exchange regarding 'Intimation as per Regulation 30 of SEBI (LODR) Regulations, 2015 '.
06-Feb-2023 14-Feb-2023 Quarterly Results To consider and approve the financial results for the period ended December 31, 2022 Ajooni Biotech Limited has informed the Exchange regarding revised Outcome of Board Meeting held on February 14, 2023. Ajooni Biotech Limited has informed the Exchange regarding Corrigendum to outcome of Board meeting Ajooni Biotech Limited has informed the Exchange regarding 'Approval of Un-audited Financial Results for the quarter ended December 31, 2022'. Ajooni Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on February 14, 2023. (As Per NSE Announcement Dated on 14/02/2023) Ajooni Biotech Limited has informed the Exchange regarding 'Financial Statement'. (As Per NSE Announcement Dated on 15/02/2023)
31-Oct-2022 11-Nov-2022 Quarterly Results Ajooni Biotech Limited has informed the Exchange about Board Meeting to be held on 11-Nov-2022 to consider un-audited financial statements for the period ended 30th September 2022 Ajooni Biotech Limited has informed the Exchange about Board Meeting held on 11-Nov-2022 to consider financial statements for the period ended September 2022. (As Per NSE Announcement Dated on 11.11.2022)
1 2 3 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.
+91-22-25229720
+91-9769005430
>info@capitalmarket.com

For any Capital Market Website related queries mail to :
webdesk@capitalmarket.com

For Capital Market Magazine subscription queries :
+91-8657545825  

subscription@capitalmarket.com

For Capital Market Online Product related queries :
+91-8657545825  

financeshop@capitalmarket.com

To advertise on Capital Market Websites mail to :
advt@capitalmarket.com

To email Press Releases :
pressrelease@capitalmarket.com

Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages giving any kind of stock recommendations.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +